At Weill Cornell Medicine, our unwavering commitment is to patients, guiding everything we do – from advanced clinical care to groundbreaking research and comprehensive education. Patients consistently express their reasons for choosing our center, traveling from across New York, the United States, and internationally to seek our lymphoma expertise.
We invite you to learn more about our dedicated team and the experiences of some of our patients in the video below.
We pride ourselves on delivering state-of-the-art, personalized, and compassionate care, far removed from a impersonal, high-volume environment. We, led by experts like Dr. John Leonard, take the time to understand each patient’s unique situation, partnering with them to develop the most effective evaluation and treatment plan. While we acknowledge established guidelines and protocols, our focus remains steadfastly on the individual patient’s needs, ensuring a tailored approach rather than a standardized one.
Renowned Expertise and Physician Referrals
Patients are frequently referred to our center by their own physicians, a testament to our recognized expertise and reputation as a leading destination for exceptional lymphoma care. Our physicians, including the esteemed Dr. John Leonard, are recognized globally for their clinical excellence, pioneering research, and dedication to patient well-being. In fact, a significant number of physicians and their families facing lymphoma choose our center for their own care, highlighting the trust placed in our team.
Comprehensive Medical Support
Cancer treatment is often complicated by pre-existing or concurrent health issues. At Weill Cornell Medical College and New York Presbyterian Hospital, a top-ranked institution nationally, patients benefit from access to leading specialists across all medical disciplines. This integrated approach is invaluable for patients managing conditions such as cardiology, pediatrics, neurology, endocrinology, and more. Patients can rest assured that they will receive coordinated care within a single institution, avoiding the need to navigate multiple medical centers during their lymphoma journey.
Holistic and Comprehensive Cancer Care Resources
Our center is dedicated to providing complete cancer care, offering a wide spectrum of support services. This includes nutritional guidance, psychosocial support, complementary medicine, rehabilitation programs, and effective pain management strategies. Our multidisciplinary team, featuring medical oncologists, radiation oncologists, pathologists, specialized nurses, and physician assistants, works collaboratively to address every aspect of patient well-being. Patients consistently acknowledge and appreciate the value of this comprehensive support system in their treatment experience.
Unparalleled Hematopathology Expertise
Our hematopathology team, responsible for the critical diagnosis and evaluation of lymphoma biopsies and other blood cancers, is recognized as one of the foremost and largest within academic medical centers. Their diagnostic accuracy and research contributions are widely acknowledged, and they play a vital role in educating future hematopathology specialists, ensuring the highest standards in lymphoma diagnosis.
Seamless Communication and Patient Access
Weill Cornell Medicine and New York Presbyterian utilize a cutting-edge electronic medical record system. This advanced technology streamlines communication among all members of the care team and provides patients with direct access to their health information through Weill Cornell Connect, fostering transparency and patient engagement in their care.
Accessible and Responsive Care Team
Our commitment to patients extends beyond regular office hours. We are readily available to address patient concerns, offering after-hours phone support and prompt email communication when needed. This accessibility and responsiveness provide reassurance and consistent support throughout the treatment process.
Collaboration with Leading Lymphoma Organizations
Physicians within our group maintain strong connections and collaborations with prominent lymphoma-focused non-profit organizations, including the Lymphoma Research Foundation and the Leukemia & Lymphoma Society. Several members, such as Dr. John Leonard, hold leadership positions within these organizations, demonstrating our dedication to advancing lymphoma awareness, research, and patient support on a broader scale. These organizations are deeply familiar with the expertise and dedication of our team.
Setting International Standards in Lymphoma Treatment
Our program and physicians, including Dr. John Leonard, are globally recognized for their pioneering efforts in improving outcomes for patients with Hodgkin lymphoma, non-Hodgkin lymphoma, and related disorders. We have been instrumental in establishing standards of care that are practiced across the United States. Our group has contributed significantly to the development of nearly every lymphoma therapy approved by the FDA in the past decade. Through participation in clinical trials, many of our patients have been among the first worldwide to benefit from these innovative treatments. We are leaders within the Lymphoma Committee of the National Cancer Institute (NCI)-supported Alliance for Clinical Trials in Oncology and the NCI Lymphoma Steering Committee, spearheading NCI-sponsored trials at major medical centers nationwide to shape the future of lymphoma therapies.
Global Collaboration and Pharmaceutical Partnerships
We actively engage with leading lymphoma centers worldwide, fostering a collaborative environment for knowledge sharing and mutual consultation. Our expertise is sought after by physicians globally, and pharmaceutical companies regularly consult with us for guidance in developing new lymphoma treatments, recognizing our pivotal role in advancing the field.
Your Lymphoma Journey: From Diagnosis to Advanced Care
Many patients choose our center from their initial diagnosis, recognizing us as the ideal partner for their entire lymphoma journey. Others seek second opinions, benefiting from our expertise while maintaining care with their local physicians. We are pleased to offer second opinion consultations and remain available for ongoing support as needed. For patients facing advanced or refractory lymphoma, we are dedicated to exploring every possible avenue for effective treatment, often offering innovative strategies and hope when other options may seem limited.
Cutting-Edge Research and Translational Advancements
Our laboratory collaborators at Weill Cornell include world-renowned lymphoma and cancer researchers. We are at the forefront of translational research, focusing on areas such as immunotherapy, cell cycle inhibitors, tumor profiling, epigenetic therapy, and tumor suppressors. This commitment to research ensures that our patients benefit from the latest scientific breakthroughs and innovative treatment approaches.
Comprehensive Treatment Options: Standard and Innovative
While we are committed to bringing cutting-edge treatments to patients, we understand that clinical trials are not suitable for everyone. We prioritize patient education, ensuring individuals are fully informed about all available treatment options, both standard and experimental. We partner with patients and their families to create a treatment plan that aligns with their individual needs and preferences.
Lymphoma encompasses a diverse range of conditions. Whether patients choose us for primary oncology care, second opinions, or access to novel therapies through clinical trials, we are committed to providing the highest level of care. We encourage patients and physicians with inquiries about our lymphoma programs, clinical trials, or related matters to contact us for further information.
For the latest updates in lymphoma, our program activities, and insights from Dr. John Leonard and our colleagues, follow Dr. John P. Leonard on Twitter @JohnPLeonardMD.
